期刊
NEUROBIOLOGY OF AGING
卷 32, 期 5, 页码 821-833出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2009.05.012
关键词
beta-Amyloid; Alzheimer; BDNF; Neurotrophin; Axonal transport; Microfluidic chamber
资金
- NIH [AG00538, AGO 16573, AG000096, AG029378]
The neurotrophin, brain-derived neurotrophic factor (BDNF), is essential for synaptic function, plasticity and neuronal survival. At the axon terminal, when BDNF binds to its receptor, tropomyosin-related kinase B (TrkB), the signal is propagated along the axon to the cell body, via retrograde transport, regulating gene expression and neuronal function. Alzheimer disease (AD) is characterized by early impairments in synaptic function that may result in part from neurotrophin signaling deficits. Growing evidence suggests that soluble beta-amyloid (A beta) assemblies cause synaptic dysfunction by disrupting both neurotransmitter and neurotrophin signaling. Utilizing a novel microfluidic culture chamber, we demonstrate a BDNF retrograde signaling deficit in AD transgenic mouse neurons (Tg2576) that can be reversed by gamma-secretase inhibitors. Using BDNF-GFP, we show that BDNF-mediated TrkB retrograde trafficking is impaired in Tg2576 axons. Furthermore, A beta oligomers alone impair BDNF retrograde transport. Thus, A beta reduces BDNF signaling by impairing axonal transport and this may underlie the synaptic dysfunction observed in AD. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据